Bristol Myers Squibb (BMS) is deploying Anthropic’s Claude across roughly 30,000 employees, according to reports citing company and deal details. The rollout is intended to bring the AI assistant into BMS’s day-to-day work across enterprise functions, rather than limiting use to a small pilot group. The agreement signals a broader push by both companies: BMS expands its use of generative AI in corporate operations, while Anthropic deepens its presence in the life sciences sector and seeks additional enterprise customers.
While the sources do not specify the full scope of which internal tasks Claude will support, the companies’ descriptions emphasize scale—serving a large portion of BMS’s workforce—and enterprise deployment rather than consumer or limited trial use. The deal also reflects an effort to integrate AI tools into large organizations with established compliance and operational requirements.
